English
Polski
Español
українська
How to manage moderate SIAD?
What management is recommended in moderate syndrome of inappropriate diuresis? With Dr Ally Prebtani.
2024-10-23
What management is recommended in moderate syndrome of inappropriate diuresis? With Dr Ally Prebtani.
How to manage patients with acute signs and symptoms of syndrome of inappropriate diuresis, including rapidly progressing hyponatremia? With Dr Ally Prebtani.
When to suspect and how to diagnose syndrome of inappropriate antidiuresis? With Dr Ally Prebtani.
With the current progress of medicine, can we expect that the use of insulin in people with type 2 diabetes will soon pass into history and the only injection therapy will involve effective drugs from the glucagon-like peptide-1 (GLP-1) receptor agonists, promoting significant weight loss?
What is the place of long-acting insulin analogues with higher than standard concentrations (200 IU/mL and 300 IU/mL) in the treatment of type 2 diabetes? In which patients should we expect the benefits to justify recommending the drug despite the higher cost to the patient?
Which model of insulin therapy is best for patients with type 2 diabetes?
When can we expect a fully autonomic closed-loop system (“artificial pancreas”) to be available for patients? Does it seem possible?
How useful and needed are continuous glucose monitoring (CGM) systems in the treatment of type 1 diabetes? Which patients should use them?
What are the advantages of insulin analogues despite their higher cost?
What should be the next step if fine-needle aspiration biopsy has revealed a benign thyroid nodule (category II according to the Bethesda classification)? Should further follow-up be planned?
